AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
NCT07009769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 865
Last updated 2025-06-08
Summary
The investigators aim to develop an AI-powered precision medicine system based on liquid biopsy that can comprehensively provide lung cancer patients with information on disease stage, histologic subtype, and presence of genetic mutations.
Conditions
Sponsors & Collaborators
-
Korea University Guro Hospital
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-16
- Primary Completion
- 2024-12-31
- Completion
- 2025-05-01
Countries
- South Korea
More Related Trials
-
Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
NCT04817046 ·Status: UNKNOWN
-
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
NCT07045103 ·Status: RECRUITING
-
Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates
NCT01482572 ·Status: WITHDRAWN
-
Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome
NCT04529915 ·Status: UNKNOWN
-
Research on New Diagnosis and Treatment Technologies for Early Lung Cancer
NCT07000721 ·Status: COMPLETED ·Phase: NA
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
NCT04253509 ·Status: COMPLETED
-
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
NCT05804786 ·Status: RECRUITING
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
NCT05517083 ·Status: COMPLETED ·Phase: NA
-
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
NCT06733311 ·Status: RECRUITING
-
Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
NCT06531343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study
NCT07331701 ·Status: NOT_YET_RECRUITING
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Symptom Collection of Lung Cancer Patients
NCT03384680 ·Status: UNKNOWN
-
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
NCT01482585 ·Status: UNKNOWN
-
Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning Model
NCT06771947 ·Status: NOT_YET_RECRUITING
-
Artificial Intelligence in Lung Cancer Screening
NCT06444373 ·Status: COMPLETED
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
NCT07239063 ·Status: RECRUITING
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Oral Microbiome Diagnostics of Lung Cancer
NCT06270992 ·Status: RECRUITING
-
Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer
NCT06301295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Korean Lung Cancer Screening Project
NCT03394703 ·Status: UNKNOWN
-
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473 ·Status: RECRUITING